| Justin T Lee, MD | |
|
5005 S Cooper St Ste 250, Arlington, TX 76017-5996 | |
| (866) 367-8768 | |
| (817) 541-9540 |
| Full Name | Justin T Lee |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 28 Years |
| Location | 5005 S Cooper St Ste 250, Arlington, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023004413 | NPI | - | NPPES |
| 150756804 | Other | TX | MEDICAID OTHER |
| 150756801 | Medicaid | TX | |
| 150756802 | Medicaid | TX | |
| 150756803 | Medicaid | TX | |
| 150756805 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | L3726 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| U S M D Hospital At Arlington L P | Arlington, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Urology Partners Of North Texas, Pllc | 7315283454 | 46 |
News Archive
McGill University researchers have unlocked a new door to developing drugs to slow the progression of Parkinson's disease. Collaborating teams led by Dr. Edward A. Fon at the Montreal Neurological Institute and Hospital -The Neuro, and Dr. Kalle Gehring in the Department of Biochemistry at the Faculty of Medicine, have discovered the three-dimensional structure of the protein Parkin.
Accurate diagnosis of Parkinson's disease, and the related disease "dementia with Lewy bodies," can be difficult in the early stages of both conditions. While brain biopsies can be more accurate, the risk of complications has been considered too high. New research published in the Journal of Parkinson's Disease indicates that a biopsy of the submandibular gland can help identify the same pathology that is seen in the brain, providing some of the increased accuracy of brain biopsy, but not the increased risk.
CytRx Corporation a biopharmaceutical company specializing in oncology, today announced that it has been awarded a nontaxable grant of approximately $735,000 related to its INNO-206, tamibarotene and bafetinib programs under the Qualifying Therapeutic Discovery Project Program included in the Patient Protection and Affordable Care Act, H.R. 3590, signed into law in March 2010.
Disease activity in patients with rheumatoid arthritis (RA) is significantly reduced during pregnancy, according to new data presented today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain.
The new 10-20-30 training concept can improve both a person's running performance and health, despite a significant reduction in the total amount of training. This is the conclusion of a study from University of Copenhagen researchers just published in the renowned scientific Journal of Applied of Physiology.
› Verified 5 days ago
| Entity Name | Urology Partners Of North Texas, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528537180 PECOS PAC ID: 7315283454 Enrollment ID: O20190110003363 |
News Archive
McGill University researchers have unlocked a new door to developing drugs to slow the progression of Parkinson's disease. Collaborating teams led by Dr. Edward A. Fon at the Montreal Neurological Institute and Hospital -The Neuro, and Dr. Kalle Gehring in the Department of Biochemistry at the Faculty of Medicine, have discovered the three-dimensional structure of the protein Parkin.
Accurate diagnosis of Parkinson's disease, and the related disease "dementia with Lewy bodies," can be difficult in the early stages of both conditions. While brain biopsies can be more accurate, the risk of complications has been considered too high. New research published in the Journal of Parkinson's Disease indicates that a biopsy of the submandibular gland can help identify the same pathology that is seen in the brain, providing some of the increased accuracy of brain biopsy, but not the increased risk.
CytRx Corporation a biopharmaceutical company specializing in oncology, today announced that it has been awarded a nontaxable grant of approximately $735,000 related to its INNO-206, tamibarotene and bafetinib programs under the Qualifying Therapeutic Discovery Project Program included in the Patient Protection and Affordable Care Act, H.R. 3590, signed into law in March 2010.
Disease activity in patients with rheumatoid arthritis (RA) is significantly reduced during pregnancy, according to new data presented today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain.
The new 10-20-30 training concept can improve both a person's running performance and health, despite a significant reduction in the total amount of training. This is the conclusion of a study from University of Copenhagen researchers just published in the renowned scientific Journal of Applied of Physiology.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Justin T Lee, MD 5001 S Cooper St Ste 201, Arlington, TX 76017-5993 Ph: (866) 367-8768 | Justin T Lee, MD 5005 S Cooper St Ste 250, Arlington, TX 76017-5996 Ph: (866) 367-8768 |
News Archive
McGill University researchers have unlocked a new door to developing drugs to slow the progression of Parkinson's disease. Collaborating teams led by Dr. Edward A. Fon at the Montreal Neurological Institute and Hospital -The Neuro, and Dr. Kalle Gehring in the Department of Biochemistry at the Faculty of Medicine, have discovered the three-dimensional structure of the protein Parkin.
Accurate diagnosis of Parkinson's disease, and the related disease "dementia with Lewy bodies," can be difficult in the early stages of both conditions. While brain biopsies can be more accurate, the risk of complications has been considered too high. New research published in the Journal of Parkinson's Disease indicates that a biopsy of the submandibular gland can help identify the same pathology that is seen in the brain, providing some of the increased accuracy of brain biopsy, but not the increased risk.
CytRx Corporation a biopharmaceutical company specializing in oncology, today announced that it has been awarded a nontaxable grant of approximately $735,000 related to its INNO-206, tamibarotene and bafetinib programs under the Qualifying Therapeutic Discovery Project Program included in the Patient Protection and Affordable Care Act, H.R. 3590, signed into law in March 2010.
Disease activity in patients with rheumatoid arthritis (RA) is significantly reduced during pregnancy, according to new data presented today at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain.
The new 10-20-30 training concept can improve both a person's running performance and health, despite a significant reduction in the total amount of training. This is the conclusion of a study from University of Copenhagen researchers just published in the renowned scientific Journal of Applied of Physiology.
› Verified 5 days ago
Dr. Andrew C Sambell, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 801 W Interstate 20 Ste 1, Arlington, TX 76017 Phone: 817-784-8268 Fax: 817-417-1151 | |
Andrew Yang Sun, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 5005 S Cooper St Ste 250, Arlington, TX 76017 Phone: 866-367-8768 | |
Keith Rohan Xavier, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 5005 S Cooper St Ste 250, Arlington, TX 76017 Phone: 866-367-8768 Fax: 817-541-9540 | |
Dr. Dominic Tang, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 801 W Interstate 20 Ste 1, Arlington, TX 76017 Phone: 817-784-8268 Fax: 817-417-1150 | |
Esther Han, D.O. Urology Medicare: Accepting Medicare Assignments Practice Location: 811 W Interstate 20 Ste 114, Arlington, TX 76017 Phone: 817-784-8268 Fax: 817-804-8178 | |
Dr. Mark Alan Mccurdy, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 811 W Interstate 20 Ste 114, Arlington, TX 76017 Phone: 817-784-8268 Fax: 817-804-8178 |